| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Loss before income tax benefit | -1,388 | - | ||
| Income tax benefit | 0 | - | ||
| Net loss | -1,388 | -1,075 | ||
| Net loss per share of common stock, basic | -0.01 | 0 | ||
| Net loss per share of common stock, diluted | -0.01 | 0 | ||
| Weighted average number of shares outstanding, diluted | 98,503,430 | 98,503,430 | ||
| Weighted-average shares of common stock outstanding, basic | 98,503,430 | 98,503,430 | ||
Galera Therapeutics, Inc. (GRTX)
Galera Therapeutics, Inc. (GRTX)